Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression

Liver metastasis is a major cause of mortality in colorectal cancer (CRC). The current study was to investigate the ability of ulinastatin (UTI) and curcumin (CUR) to inhibit CRC liver metastases via modulating matrix metalloproteinase-9 (MMP-9) and E-cadherin expression. Human CRC HCT-116 cells wer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shen, Fei, Cai, Wen-Song, Li, Jiang-Lin, Feng, Zhe, Liu, Qi-cai, Xiao, Huan-qing, Cao, Jie, Xu, Bo
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2014
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3933719/
https://ncbi.nlm.nih.gov/pubmed/24570592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S57126
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars